Take That, Death
Summary
Host Ben Bradford explores the scientific quest to reverse aging, featuring reporter Susan Domis. They discuss how Nobel laureate Shinya Yamanaka discovered cellular reprogramming factors that can revert cells to a younger state, leading to breakthroughs in mouse rejuvenation. The episode examines the race by secretive, billionaire-funded labs like Altos Labs to develop human treatments, currently testing cellular rejuvenation for glaucoma. While the technology could extend healthy lifespan, it raises profound ethical questions about inequality, safety risks, and the societal impact of pote…
Topics discussed
Sponsor and show schedule update
Introduction: The myth of eternal life
Why animals age at different rates
Cynthia Kenyon's roundworm gene discovery
The cement analogy and mesenchymal drift
Evolutionary perspective on aging
Why babies are born young: The cellular reset
Shinya Yamanaka and the discovery of iPS cells
The mouse experiment: Teratomas and failure
Partial reprogramming: Rejuvenating mice
The longevity industry and billionaire investors
Inside Altos Labs: Organoids and human cells
Concerns over secrecy and corporate control
NPR podcast promotions
Recap and the question of doom
Current human trials: Glaucoma and safety
Optimistic future: Extending healthy lifespan
Dystopian risks: Inequality and power consolidation
Quality of life vs. longevity and FDA hurdles
Next episode preview and credits
Listen ad-free on Castria